CoChat

Weight Loss at First Month and Development of Tolerance as Possible Predictors of 30 mg Phentermine Efficacy at 6 Months

Open access
Rocha-González, Héctor Isaac, De la Cruz-Álvarez, Lidia Elizabeth, Kammar-García, Ashuin, Canizales-Quinteros, Samuel, Huerta-Cruz, Juan Carlos, Barranco-Garduño, Lina Marcela, Reyes-García, Juan Gerardo · 2021 · Journal of Personalized Medicine

The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index, and 1 are not checked yet.

Abstract

The efficacy of anti-obesity drugs usually does not consider the high degree of interindividual variability in responses to the drug which could affect the decision to withdraw the drug early due to ineffectiveness or to continue therapy according to specific expectations of success. The aim of this study was to analyze body weight loss in kilograms during the first month (1 mo-BWLkg) of treatment with 30 mg phentermine and development of tolerance to phentermine, on its 6-month efficacy. One hundred sixty-six subjects with obesity were individually or jointly analyzed in the study. Subjects with 1 mo-BWLkg of <1 kg, 1–3 kg, 3–5 kg, and ≥5 kg reached 6-month mean percentage body weight reductions (BWR%) of approximately 3%, 5%, 10%, and 15%, respectively. Development of late tolerance (4–6 months) to phentermine had a lower impact than early tolerance (2–3 months). Subjects with 1 mo-BWLkg < 3 kg who developed early tolerance did not achieve relevant BWR% (≥5%) at month 6, while the rest of the subgroups achieved increasing and progressive BWR%, according to their 1 mo-BWLkg range and time of onset of tolerance. The 1 mo-BWLkg and development of tolerance to phentermine could be useful to predict the expected 6-month efficacy trends in obese patients treated with 30 mg phentermine.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jpm11121354

Cites

32 of 33 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Variability in the body weight loss in kilograms (BWLkg) for every time point in the 6-month follow-up period, induced by 30 mg phentermine in 166 patients with obesity. Each point represents the weight loss by one subject for any given month, whereas the line shows the trend of average weight loss for every month. BWLkg = Body weight loss in kilograms.
Figure 1 Variability in the body weight loss in kilograms (BWLkg) for every time point in the 6-month follow-up period, induced by 30 mg phentermine in 166 patients with obesity. Each point represents the weight loss by one subject for any given month, whereas the line shows the trend of average weight loss for every month. BWLkg = Body weight loss in kilograms.CC BY · PubMed Central
Figure 2 Six-month time course trends of 30 mg phentermine effect on percentage body weight reduction (BWR%) according to body weight loss in kilograms during the first month (A), development of tolerance to phentermine (B), and obesity class (C). Each point represents the mean. Standard deviations were omitted to allow visualization of overlapping traces. 1 mo-BWLkg: body weight loss in kilograms during the first month, kg: kilograms, n: sample size, NT: No tolerance, 6 moT: Tolerance at month 6, 5 moT: Tolerance at month 5, 4 moT: Tolerance at month 4, 3 moT: Tolerance at month 3, 2 moT: Tolerance at month 2.
Figure 2 Six-month time course trends of 30 mg phentermine effect on percentage body weight reduction (BWR%) according to body weight loss in kilograms during the first month (A), development of tolerance to phentermine (B), and obesity class (C). Each point represents the mean. Standard deviations were omitted to allow visualization of overlapping traces. 1 mo-BWLkg: body weight loss in kilograms during the first month, kg: kilograms, n: sample size, NT: No tolerance, 6 moT: Tolerance at month 6, 5 moT: Tolerance at month 5, 4 moT: Tolerance at month 4, 3 moT: Tolerance at month 3, 2 moT: Tolerance at month 2.CC BY · PubMed Central
Figure 3 Three- and six-month mean percentage body weight reduction (BWR%) efficacy of 30 mg phentermine, according to body weight loss in kilograms during the first month (1 mo-BWLkg) and development of tolerance to phentermine. Tolerance was divided into no tolerance (A,B), late tolerance (C,D), tolerance at month 3 (E,F), and tolerance at month 2 (G,H). Each point represents the mean BWR% value and bars represent 95% confidence intervals (A,C,E,G) or the percentage of subjects who achieved a % interval of efficacy (B,D,F,H). * Significantly different by Student’s t-test (p < 0.05).
Figure 3 Three- and six-month mean percentage body weight reduction (BWR%) efficacy of 30 mg phentermine, according to body weight loss in kilograms during the first month (1 mo-BWLkg) and development of tolerance to phentermine. Tolerance was divided into no tolerance (A,B), late tolerance (C,D), tolerance at month 3 (E,F), and tolerance at month 2 (G,H). Each point represents the mean BWR% value and bars represent 95% confidence intervals (A,C,E,G) or the percentage of subjects who achieved a % interval of efficacy (B,D,F,H). * Significantly different by Student’s t-test (p < 0.05).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Cited by

See all 10

Metadata

Authors
Rocha-González, H. I., De la Cruz-Álvarez, L. E., Kammar-García, A., Canizales-Quinteros, S., Huerta-Cruz, J. C., Barranco-Garduño, L. M., & Reyes-García, J. G.
Affiliations
  • Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón s/n, Col. Casco de Santo Tomas, Miguel Hidalgo, Mexico City 11340, Mexico
  • Facultad de Química, Universidad Nacional Autónoma de México, Circuito Escolar S/N, Ciudad Universitaria, Coyoacán, Mexico City 04510, Mexico
  • Unidad de Investigación en Farmacología, Instituto Nacional de Enfermedades Respiratorias, Ismael Cosio Villegas, Secretaría de Salud, Calzada de Tlalpan 4502, Col. Belisario Domínguez Sección XVI, Tlalpan, Mexico City 14080, Mexico
  • Instituto Politécnico Nacional (MX)
Corresponding author
Reyes-García, Juan Gerardo
Venue
Journal of Personalized Medicine
Publisher
MDPI AG
Published
2021-12-12
Volume
11
Issue
12
Pages
1354
ISSN
2075-4426 (ISSN-L)
OpenAlex
W4200311552
Cited by
10
References
31
Citations by year
2026: 1 · 2024: 6 · 2022: 2
FWCI
1.17
Type
journal article
Language
en
Open access
Locations
  • Journal of Personalized Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
Consejo Nacional de Ciencia y Tecnología (213481)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
Keywords
phentermine, obesity, weight loss, drug tolerance, treatment efficacy prediction, anti-obesity drugs, interindividual variability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Weight Loss at First Month and Development of Tolerance as Possible Predictors of 30 mg Phentermine Efficacy at 6 Months. https://app.cochat.ai/papers/10.3390/jpm11121354
The paper
Rocha-González, H. I., De la Cruz-Álvarez, L. E., Kammar-García, A., Canizales-Quinteros, S., Huerta-Cruz, J. C., Barranco-Garduño, L. M., & Reyes-García, J. G. (2021). Weight Loss at First Month and Development of Tolerance as Possible Predictors of 30 mg Phentermine Efficacy at 6 Months. Journal of Personalized Medicine. https://doi.org/10.3390/jpm11121354

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.